Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN, Ireland and TREVOSE, Pa., July 26, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (Nasdaq: SBBP), a global commercial-stage biopharmaceutical…
Rapid reduction and sustained normalization of heparan sulfate in CSF demonstrated robust and durable CNS activity with intravenous administration, and…
New Saturn-1 data demonstrated a strong patient responder rate with 95% of Demodex blepharitis patients treated with TP-03 achieving ≤0.5…
Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction, Showcasing the Power of Biosimulation TechnologyPRINCETON, N.J., July 23, 2021 (GLOBE NEWSWIRE)…
RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14…
EDISON, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the…
CAMBRIDGE, Mass., July 23, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced it will share multiple oral and…
Reno, Nevada, July 23, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC Pink: XLPI) today announced a 1-for-100 reverse split…
China Oncology Focus, a subsidiary of Lee’s Pharm, has enrolled the first patient in the Socazolimab double-blinded Phase 3 study…
FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011505(b)(2) regulatory strategy: acceptable approach upon…